• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

畸形学的监管方面:美国食品药品监督管理局的作用

Regulatory aspects of teratology: role of the Food and Drug Administration.

作者信息

Kelsey F O

出版信息

Teratology. 1982 Apr;25(2):193-9. doi: 10.1002/tera.1420250208.

DOI:10.1002/tera.1420250208
PMID:7048616
Abstract

The Food and Drug Administration is a scientific regulatory agency whose consumer protection activities cover a wide range of products including foods and additives, and pesticide residues on foods; drugs; cosmetics; medical devices; and radiation-emitting electronic products. Amongst its concerns is the possible teratogen effects of regulated products to which the pregnant woman is exposed. The policies and programs of the agency directed toward reducing such risks to the unborn are reviewed. These measures include guidelines for animal reproduction studies and for clinical trials involving women to childbearing potential; labeling of products to disclose known or possible harm to the fetus or embryo; surveillance procedures designed to detect previously unsuspected adverse effects of marketed products; research activities designed to develop better understanding of developmental toxicology and improved techniques for detecting embryocidal and embryotoxic effects; and educational efforts directed both to professionals and the public regarding hazards to the unborn of agency-regulated products.

摘要

美国食品药品监督管理局是一个科学监管机构,其消费者保护活动涵盖广泛的产品,包括食品和添加剂、食品上的农药残留、药品、化妆品、医疗器械以及发射辐射的电子产品。该机构关注的问题之一是孕妇接触到的受监管产品可能产生的致畸作用。本文回顾了该机构旨在降低对未出生胎儿此类风险的政策和计划。这些措施包括动物生殖研究指南以及涉及有生育潜力女性的临床试验指南;产品标签,以披露已知或可能对胎儿或胚胎造成的危害;监测程序,旨在检测市售产品先前未被怀疑的不良反应;研究活动,旨在更好地理解发育毒理学并改进检测胚胎致死和胚胎毒性作用的技术;以及针对专业人员和公众开展的关于该机构监管产品对未出生胎儿危害的教育工作。

相似文献

1
Regulatory aspects of teratology: role of the Food and Drug Administration.畸形学的监管方面:美国食品药品监督管理局的作用
Teratology. 1982 Apr;25(2):193-9. doi: 10.1002/tera.1420250208.
2
Teratogen update: evaluation of the reproductive and developmental risks of caffeine.致畸剂最新情况:咖啡因生殖与发育风险评估
Teratology. 2001 Jul;64(1):51-78. doi: 10.1002/tera.1047.
3
Reproductive toxicology guidelines: comparison and application.
Ann Ist Super Sanita. 1993;29(1):3-14.
4
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
5
Methods of evaluating the alleged teratogenicity of environmental agents.评估环境因素潜在致畸性的方法。
Prog Clin Biol Res. 1985;163C:191-5.
6
The history and contemporary challenges of the US Food and Drug Administration.美国食品药品监督管理局的历史与当代挑战
Clin Ther. 2007 Jan;29(1):1-16. doi: 10.1016/j.clinthera.2007.01.006.
7
The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.美国食品药品监督管理局新的药品说明书:对患者安全和临床护理的影响。
Anesth Analg. 2009 Jan;108(1):211-8. doi: 10.1213/ane.0b013e31818c1b27.
8
Knowledge transfer and translation: examining how teratogen information is disseminated.知识转移与转化:审视致畸物信息的传播方式。
Birth Defects Res A Clin Mol Teratol. 2011 Nov;91(11):956-61. doi: 10.1002/bdra.22851. Epub 2011 Sep 22.
9
Regulatory issues concerning the safety, efficacy and quality of herbal remedies.关于草药疗法的安全性、有效性和质量的监管问题。
Birth Defects Res B Dev Reprod Toxicol. 2003 Dec;68(6):505-10. doi: 10.1002/bdrb.10053.
10
Lessons learned from independent central review.独立中央审查的经验教训。
Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031.